Literature DB >> 30048709

Bioactive lysolipids in cancer and angiogenesis.

Yu Hisano1, Timothy Hla2.   

Abstract

While normal angiogenesis is critical for development and tissue growth, pathological angiogenesis is important for the growth and spread of cancers by supplying nutrients and oxygen as well as providing a conduit for distant metastasis. The interaction among extracellular matrix molecules, tumor cells, endothelial cells, fibroblasts, and immune cells is critical in pathological angiogenesis, in which various angiogenic growth factors, chemokines, and lipid mediators produced from these cells as well as hypoxic microenvironment promote angiogenesis by regulating expression and/or activity of various related genes. Sphingosine 1-phosphate and lysophosphatidic acid, bioactive lipid mediators which act via specific G protein-coupled receptors, play critical roles in angiogenesis. In addition, other lipid mediators including prostaglandin E2, lipoxin, and resolvins are produced in a stimulus-dependent manner and have pro- or anti-angiogenic effects, presumably through their specific GPCRs. Dysregulated lipid mediator signaling pathways are observed in the contxt of some tumors. This review will focus on LPA and S1P, two bioactive lipid mediators in their regulation of angiogenesis and cell migration that are critical for tumor growth and spread.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Angiogenesis; Cancer; Lipid mediator; Migration; Sphingosine 1-phosphate

Mesh:

Substances:

Year:  2018        PMID: 30048709      PMCID: PMC6309747          DOI: 10.1016/j.pharmthera.2018.07.006

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  144 in total

1.  Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

Authors:  Koichi Sato; Fumikazu Okajima
Journal:  World J Biol Chem       Date:  2010-11-26

Review 2.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.

Authors:  Hugh Rosen; Edward J Goetzl
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

Review 3.  The role of high-density lipoproteins in the regulation of angiogenesis.

Authors:  Joanne T M Tan; Martin K C Ng; Christina A Bursill
Journal:  Cardiovasc Res       Date:  2015-03-10       Impact factor: 10.787

4.  An engineered S1P chaperone attenuates hypertension and ischemic injury.

Authors:  Steven L Swendeman; Yuquan Xiong; Anna Cantalupo; Hui Yuan; Nathalie Burg; Yu Hisano; Andreane Cartier; Catherine H Liu; Eric Engelbrecht; Victoria Blaho; Yi Zhang; Keisuke Yanagida; Sylvain Galvani; Hideru Obinata; Jane E Salmon; Teresa Sanchez; Annarita Di Lorenzo; Timothy Hla
Journal:  Sci Signal       Date:  2017-08-15       Impact factor: 8.192

5.  Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase.

Authors:  Christelle Benaud; Michael Oberst; John P Hobson; Sarah Spiegel; Robert B Dickson; Chen-Yong Lin
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

6.  Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.

Authors:  Patrick A Singleton; Steven M Dudek; Eddie T Chiang; Joe G N Garcia
Journal:  FASEB J       Date:  2005-10       Impact factor: 5.191

7.  The Sjögren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway.

Authors:  Kanae Nakahara; Aya Ohkuni; Takuya Kitamura; Kensuke Abe; Tatsuro Naganuma; Yusuke Ohno; Raphael A Zoeller; Akio Kihara
Journal:  Mol Cell       Date:  2012-05-25       Impact factor: 17.970

8.  Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.

Authors:  Jeremy J W Chen; Pei-Li Yao; Ang Yuan; Tse-Ming Hong; Chia-Tung Shun; Min-Liang Kuo; Yung-Chie Lee; Pan-Chyr Yang
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

9.  PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway.

Authors:  Arántzazu Alfranca; Juan Manuel López-Oliva; Laura Genís; Dolores López-Maderuelo; Isabel Mirones; Dolores Salvado; Antonio J Quesada; Alicia G Arroyo; Juan Miguel Redondo
Journal:  Blood       Date:  2008-06-09       Impact factor: 22.113

Review 10.  Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells.

Authors:  S Spiegel; A Olivera; H Zhang; E W Thompson; Y Su; A Berger
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more
  31 in total

1.  Regulation of PLPP3 gene expression by NF-κB family transcription factors.

Authors:  Guogen Mao; Susan S Smyth; Andrew J Morris
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

2.  Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid.

Authors:  Maria P Kraemer; Guogen Mao; Courtney Hammill; Baoxiang Yan; Yu Li; Fredrick Onono; Susan S Smyth; Andrew J Morris
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

3.  Vascular regeneration in adult mouse cochlea stimulated by VEGF-A165 and driven by NG2-derived cells ex vivo.

Authors:  Xiaohan Wang; Jinhui Zhang; Guangshuai Li; Na Sai; Jiang Han; Zhiqiang Hou; Allan Kachelmeier; Xiaorui Shi
Journal:  Hear Res       Date:  2019-03-29       Impact factor: 3.208

Review 4.  Advances in the research of plant-derived natural products against retinoblastoma.

Authors:  Jing-Chen Liu; Chun-Li Zhang; Kai-Ye Dong; Ming-Jun Li; Shu-Guang Sun; Cai-Rui Li
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

Review 5.  The FOXO family of transcription factors: key molecular players in gastric cancer.

Authors:  Ying Liu; Xiang Ao; Yi Jia; Xiaoge Li; Yu Wang; Jianxun Wang
Journal:  J Mol Med (Berl)       Date:  2022-06-10       Impact factor: 5.606

6.  A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.

Authors:  Inés González-Gil; Debora Zian; Henar Vázquez-Villa; Gloria Hernández-Torres; R Fernando Martínez; Nora Khiar-Fernández; Richard Rivera; Yasuyuki Kihara; Isabel Devesa; Sakthikumar Mathivanan; Cristina Rosell Del Valle; Emma Zambrana-Infantes; María Puigdomenech; Giovanni Cincilla; Melchor Sanchez-Martinez; Fernando Rodríguez de Fonseca; Antonio V Ferrer-Montiel; Jerold Chun; Rubén López-Vales; María L López-Rodríguez; Silvia Ortega-Gutiérrez
Journal:  J Med Chem       Date:  2019-12-16       Impact factor: 7.446

Review 7.  Lipid mechanisms in hallmarks of cancer.

Authors:  J Molendijk; H Robinson; Z Djuric; M M Hill
Journal:  Mol Omics       Date:  2020-02-17

Review 8.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  Lipase mimetic cyclodextrins.

Authors:  Youngjun Lee; Neal K Devaraj
Journal:  Chem Sci       Date:  2020-11-19       Impact factor: 9.825

10.  Purification and Characterization of a Novel Fibrinolytic Enzyme from Cipangopaludina Cahayensis.

Authors:  Tian Zhao; Jinqi Xiong; Wen Chen; Ahui Xu; Du Zhu; Jiantao Liu
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.